ERBB2 and neoplasm: The most classical criteria for BC clinical management are tumor size, lymph-node status, presence of distant metastasis, expression of estrogen and progesterone receptors (ER, PR), expression level of human epithelial growth factor receptor 2 (HER2) [11,12].